Delivery Order SPE2DB22D3501-SPE2DB24FUV54
Award Date 3/7/24
Potential Completion Date 3/8/24
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp has received a $3,116.34 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 120 tablets of the 500 mg Capecitabine pharmaceutical. As the prime contractor, Amerisourcebergen will deliver the requested pharmaceutical product to the place of performance in Conshohocken, Pennsylvania by the November 7, 2023 completion date. No set-aside designation was applied to this order, which was awarded against an indefinite...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency for Capecitabine 500 mg tablets (120-count units) valued at $1,009.98, with an ultimate completion date of December 4, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,982,789 units of the medication Capecitabine 500 mg tablets. The contract has a ceiling value of $1,938.09 and a period of performance through March 18, 2024. This delivery order was issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of...
- This federal contract award is for the delivery of Capecitabine 500 mg tablets in 120-count packages. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,404.00 and an ultimate completion date of October 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,249.40 firm fixed price delivery order is for the supply of Capecitabine 500 mg tablets, a pharmaceutical product, with a completion date of December 20, 2023. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these tablets to the DLA Troop Support Medical in Conshohocken, Pennsylvania. This...
- <p>The Defense Logistics Agency issued a $2,705.27 delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for Capecitabine 500 mg tablets (120-count).</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed price and ultimate completion date of February 9, 2026. No set-aside was used.</p>
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, has been awarded a $15,595.70 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The contract has a completion date of March 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price Delivery Order contract (SPE2DX15D3404|SPE2DX24F1ASP) by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $7,792.08 contract is for the delivery of Ibrance 125 mg Capsule 21s, a pharmaceutical product. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and DLA, which serves as the...
- Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $23,752.56 on February 2, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This competitive, firm fixed-price contract with an ultimate completion date of February 3, 2026 represents a task order executed under the company's parent organization Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The IDC, valued at $999,999,999.00...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $11,616.70 by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4557068537 - APIXABAN 5MG 60S medication. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA, which serves as the primary...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUV54Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,409.52 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 120 tablets of 500 mg Capecitabine, a chemotherapy medication. The contract has a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Generated 6/6/24, 10:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 3/7/24 |